Sign up to save your podcasts
Or
Share Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst
Cochlear (COH) gains FDA’s blessing on multiple products, but nothing appears game-changing.
View all episodes
By Morgans Financial LimitedCochlear (COH) gains FDA’s blessing on multiple products, but nothing appears game-changing.